Optimizing antigen selection for the development of tuberculosis vaccines
Authors:
Open Access
- 16 March 2024
- journal article
- review article
- Published by Elsevier in Cell Insight
- Vol. 3 (3) , 100163
Abstract
No abstract availableKeywords
Funding Information
- gansu sheng kexue jishu ting
- Lanzhou Veterinary Research Institute State Key Laboratory for Animal Disease Control and Prevention
This publication has 112 references indexed in Scilit:
- Combatting persister cells: The daunting task in post-antibiotics eraCell Insight, 2023
- Emerging SARS-CoV-2 variants: Why, how, and what's next?Cell Insight, 2022
- Single-cell transcriptomic landscape identifies the expansion of peripheral blood monocytes as an indicator of HIV-1-TB co-infectionCell Insight, 2022
- Mycobacterium tuberculosis PPE18 protein inhibits MHC class II antigen presentation and B cell response in miceEuropean Journal of Immunology, 2020
- Tuberculosis vaccine development: from classic to clinical candidatesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020
- Non-specific effects of BCG vaccine on viral infectionsClinical Microbiology and Infection, 2019
- A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive AdultsJournal of Clinical Immunology, 2013
- Trained Immunity: A Memory for Innate Host DefenseCell Host & Microbe, 2011
- Mycobacterium vaccae induces a population of pulmonary CD11c+ cells with regulatory potential in allergic miceEuropean Journal of Immunology, 2004
- Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M. bovis BCG CopenhagenElectrophoresis, 2003